This could provide novel opportunities for discovery of therapeutic and adverse effects of medications as well as to identify conditions to prevent aging, treat non-communicable and communicable diseases, given that cells with high concentration of damaged DNA, RNA or proteins or with invasive DNA and RNA molecules would be selectively eliminated from an organism receiving a Bcl-xL-specific inhibitor. The gene discussed is BCL2L1; the disease is infectious disease.